“Casein Macropeptide from Whey—A New Product Opportunity”, Food Research Quarterly, vol. 51, Nos. 1 & 2, 1991. |
“The Justification Theory: The Essential Nature of the Non-Essential Amino Acids”, Nutritional Reviews, vol. 37, No. 7, Jul. 1979. |
“Increased Neurotransmitter Biosynthesis in Phenylketonuria Induced by Phenylalanine Restriction or by Supplementation of Unrestricted Diet with Large Amounts of Tyrosine”, Eur. J. Pediatr. (1988): 238-245. |
“Cognition and Tyrosine Supplementation Among School-Aged Children with Phenylketonuria”, AJDC, vol. 146, Nov. 1992. |
“Increased Vigilance and Dopamine Synthesis by Large Doses of Tyrosine or Phenylalanine Restriction in Phenylketonuria”, Acta Peadiatr. Scand., 76: 560-565, 1987. |
“Phenylketonuria Due to Phenylalanine Hydroxylase Deficiency: An Unfolding Story”, BMJ, vol. 306, Jan. 1993. |
“Clinical Trial of a Concentrated Amino Acid Formula for Older Patients with PKU”, E. J. Clin. Nutrit., (1988), 42: 81-86. |
“Review of Current Practices in Management of Inherited Disorders of Amino Acid Metabolism in Western Europe”, Human Nutrition: Applied Nutrition (1986), 40A, Suppl. 1, 61-69. |
“Diet Treatment of PKU UAB No. 46”, Commonwealth Agricultural Bureau (1980). |
“Phenylketonuria”, Ann. Rev. Nutr. (1987), 7:117-135. |
Observations by a third party. |
Kecskemethy et al., “The Use of Gelatin Capsules for Ingestion of Formula in Dietary Treatment of Maternal Phenylketonuria”, J. Inher. Metab. Dis., vol. 16, 1993, pp. 111-118. |
Kitagawa et al., “Treatment of Phenylketonuria with a Formula Consisting of Low-Phenylalanine Peptide”, Enzyme, vol. 38, 1987, pp. 321-327. |